Previous 10 | Next 10 |
R1 RCM press release ( NASDAQ: RCM ): Q4 GAAP EPS of -$0.09 misses by $0.04 . Revenue of $532.8M (+33.6% Y/Y) beats by $13.52M . Adjusted EBITDA of $125.0 million, up $29.9 million or 31.4% compared to the same period last year For 2023, R1 expects to generate: ...
MURRAY, Utah, Feb. 16, 2023 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced results for the three months and year ended December 31, 2022. ...
R1 RCM ( NASDAQ: RCM ) is scheduled to announce Q4 earnings results on Thursday, February 16th, before market open. The consensus EPS Estimate is $0.04 (-63.6% Y/Y) and the consensus Revenue Estimate is $519.28M (+30.2% Y/Y). Over the last 1 year, RCM has beaten EPS estimate...
MURRAY, Utah, Feb. 08, 2023 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM) (“R1”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, announced today that R1 and Cloudmed, an R1 company, we...
MURRAY, Utah, Jan. 26, 2023 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it expects to release financial results for the three months and fu...
Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. Investors are eager to herald a return to low inter...
MURRAY, Utah, Jan. 05, 2023 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced the appointment...
Summary 2022 was yet another crazy year around the world following another crazy year, the stock market being no exception. I recap some of the research I presented over the year, and some other ideas and strategies I’ve been experimenting with. Update on my personal investin...
MURRAY, Utah, Dec. 22, 2022 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced its management team will present at the 41st Annual J.P. Morgan Hea...
Summary Repositioning cross-asset and equity-focused portfolios has been a challenging affair in the latter half of FY22. Such has been the case for longs of MD, where the investment debate how now is negatively skewed to the downside. MD is faced with a series of hurdles to ramp up...
News, Short Squeeze, Breakout and More Instantly...
MURRAY, Utah, July 24, 2024 (GLOBE NEWSWIRE) -- The Special Committee of the R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”) Board of Directors, which comprises independent directors and was formed to evaluate strategic alternatives in response to the Schedule 13D/A ...
MURRAY, Utah, July 15, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it expects to release financial results for the three months ended ...
2024-07-09 09:00:05 ET George Hill from Deutsche Bank issued a price target of $16.00 for RCM on 2024-07-09 07:36:00. The adjusted price target was set to $16.00. At the time of the announcement, RCM was trading at $12.66. The overall price target consensus is at $19.00 ...